New heart valve study aims to improve lives of 1000 patients
NCT ID NCT07359898
First seen Jan 24, 2026 · Last updated May 15, 2026 · Updated 12 times
Summary
This study is testing a new heart valve called Navitor in 1000 people with severe aortic stenosis, a condition where the heart's main valve is narrowed. Participants will receive the valve through a less invasive procedure and be followed for 12 months to see how they do. The goal is to monitor real-world outcomes like survival and complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE NATIVE AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Policlinico San Donato
RECRUITINGSan Donato Milanese, Lombardy, 20097, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.